Share on StockTwits

Genus plc (LON:GNS) has earned a consensus rating of “Hold” from the eight brokerages that are presently covering the company, American Banking News.com reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is GBX 1,231.13 ($20.74).

Shares of Genus plc (LON:GNS) traded down 3.65% on Thursday, hitting GBX 1055.00. The stock had a trading volume of 724,869 shares. Genus plc has a 1-year low of GBX 924.50 and a 1-year high of GBX 1490.00. The stock has a 50-day moving average of GBX 1013. and a 200-day moving average of GBX 1189.. The company’s market cap is £638.3 million.

A number of research firms have recently commented on GNS. Analysts at N 1 Singer reiterated a “hold” rating on shares of Genus plc in a research note on Thursday. They now have a GBX 1,000 ($16.84) price target on the stock. Separately, analysts at N+1 Singer reiterated a “hold” rating on shares of Genus plc in a research note on Thursday. They now have a GBX 1,000 ($16.84) price target on the stock. Finally, analysts at N+1 Singer upgraded shares of Genus plc to a “hold” rating in a research note on Wednesday, April 23rd. They now have a GBX 1,000 ($16.84) price target on the stock.

Genus plc is a United Kingdom-based company. The Company is engaged in applying quantitative genetics and biotechnology to animal breeding in the bovine and porcine sectors.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.